| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Armata Pharmaceuticals, Inc. | SVP, Finance, and PFO | Stock Options (Right to Buy) | 25,000 | 05 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARMP | Armata Pharmaceuticals, Inc. | 05 Feb 2025 | 1 | $0 | 4 | SVP, Finance, and PFO | 07 Feb 2025, 16:17 |
| ARMP | Armata Pharmaceuticals, Inc. | 02 Oct 2024 | 1 | $0 | 4 | SVP, Finance, and PFO | 03 Oct 2024, 16:15 |
| ARMP | Armata Pharmaceuticals, Inc. | 16 Aug 2024 | 0 | $0 | 3 | SVP, Finance, and PFO | 19 Aug 2024, 16:15 |